[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100565977":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":29,"locations":35,"responsibleParty":50,"collaborators":11,"id":54,"slug":11,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":11,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":11,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":75,"whyStopped":11,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Cairo University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A: Magnesium Sulphate Iontophoresis","EXPERIMENTAL",null,[13,14],"Device: Magnesium Sulphate Iontophoresis","Other: traditional physical therapy program",{"label":16,"type":17,"description":11,"interventionNames":18},"Group B: Control","SHAM_COMPARATOR",[14],[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DEVICE","Magnesium Sulphate Iontophoresis","Iontophoretic drug delivery system (phoresors II auto model PM850 IOMED) The phoresors II auto model PM850 IOMED allows the user to deliver a specific dose from 0 to 80 mA\u002Fmin, control the current from 0 to 4 mA and automatically calculates required time for the selected dose. Current ramp-up and down, shut-off, error messages and safety checks are also performed automatically. The builtin option for manual current shut-off is an added safety feature (Teslim et al., 2013).\n\n* Electrodes: Active-Anode (Drug Delivery).\n* Drug Used: MgSO4 Aqueous Solution.\n* Drug Ion Polarity: Positive Polarity.",[9],{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"traditional physical therapy program","Deep friction massage, stretching and pressure therapy.",[9,16],[30],{"name":31,"role":32,"phone":33,"phoneExt":11,"email":34},"Aya Gamal Elsayed, PHD","CONTACT","+0201001475959","drayasa3ada@yahoo.com",[36],{"facility":5,"status":11,"city":37,"state":11,"zip":11,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Giza","Egypt",{"type":40,"coordinates":41},"Point",[42,43],31.20861,30.00944,{"lat":43,"lon":42},[46],{"name":47,"role":32,"phone":48,"phoneExt":11,"email":49},"Physical Therapy Cairo University","0237617691","Info@pt.cu.edu.eg",{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Aya Gamal Fawzy El-Sayed","Dr","100565977",false,"NCT06649188","Electromotive Drug Administration of Magnesium Sulphate on Hypertrophic Scar","Electromotive Drug Administration of Magnesium Sulphate on Hypertrophic Scar Post-Burn","Inclusion Criteria:\n\n* 1-Patient with hypertrophic scar (3-6) months after burn healing. 2-Age range between 20-40 years. 3-Male and female patients will participate in the study. 4-All patients have a post-burn hypertrophic scar at different body sites. 5-All patients enrolled on the study will have their informed consent.\n\nExclusion Criteria:\n\n\\- 1-Patients with prior medical histories of cardiac arrhythmias. 2-Patients with cardiac pacemakers. 3-Patients with orthopaedic implants. 4-Areas of skin with lesions and impaired sensation. 5-During pregnancy and breastfeeding. 6-Patient with diabetes mellitus. 7-Patients with a history of hypersensitivity or adverse reactions associated with (MgSO4).\n\n8-Recent MgSO4 administration 6 months before the study. 9-Any subject complaining of psychiatric disorders or neurological disorders such as myasthenia gravis","ALL","20 Years","40 Years",{"count":64,"type":65},80,"ESTIMATED","INTERVENTIONAL",[68],"NA","In this study 80 patients will be randomly assigned into two equal groups (40 patients for each group):\n\n1. Group A: Experimental: Magnesium Sulphate Iontophoresis for Postburn Hypertrophic Scar The study group includes 40 postburn hypertrophic scar patients will receive Magnesium Sulphate iontophoresis twice a week for 4 weeks; in addition to their traditional physical therapy program (deep friction massage, stretching and pressure therapy).\n2. Group B: Control: Traditional physical therapy for postburn hypertrophic scar This group includes 40 patients with postburn hypertrophic scar who will receive only the traditional PT (deep friction massage, stretching and pressure therapy) 2 sessions per week for 4 weeks",[71],"Hypertrophic Scars",[73,74],"Iontophoresis","Post burn","NOT_YET_RECRUITING","2024-10-17",{"date":78,"type":79},"2024-10-18","ACTUAL",{"date":81,"type":65},"2024-11-15",{"date":83,"type":65},"2025-01-15",{"name":5,"class":6},1]